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i
Regina Melendez, Xiaoxuan Cai, Cristine Hine, Brian C Merry and Kimberly Ann
Yonkers. Department of Psychiatry, Yale University, School of Medicine, New Haven,
CT.
Background: Cocaine is the third most commonly used illicit substance in pregnancy.
Few studies exist to specifically look for correlates of cocaine use in pregnancy.
Objective: To identify correlates of frequency of cocaine use in pregnancy
Methods: We analyzed retrospective data from 50 postpartum women with a history of
cocaine use or dependence who participated in a treatment trial for postpartum cocaine
use. Study variables included severity of baseline cocaine use, age of onset of use,
comorbid mental illness, poly-substance use, trauma and social support history. Data
were analyzed using GLMM Negative Binomial Regression.
Results: The strongest correlate of cocaine use in pregnancy was baseline cocaine use six
months prior to pregnancy. Daily or greater cocaine use at baseline was associated with a
2.88 increase in the degree of cocaine use in pregnancy (SD=0.57, p <0.0001) on a scale
of 0 to 8 measuring frequency of cocaine use. Weekly or greater cocaine use prior to
pregnancy was associated with a 2.58 increase in degree of cocaine use (SD= 0.57,
p<0.0001). Positive marijuana use in pregnancy was associated with a 1.24 increase in
frequency of cocaine use (SD=0.24, p<0.0001). Older age at onset of cocaine use and
higher social support scores were both significant, but weakly associated with increased
cocaine use in pregnancy. Comorbid mental illness, alcohol use and trauma history were
not statistically significant.
Conclusions: This study identified several correlates of heavier cocaine use in
pregnancy, and may help guide clinicians in improving screening and directing resources
for education of pregnant, cocaine using women.

ii

ACKNOWLEDGEMENTS
I am extremely grateful for the research opportunities provided to me by the Yale
University School of Medicine Medical Student Research Fellowship. I would like to
thank my mentor, Dr. Kimberly Ann Yonkers, for introducing me to this project, her
continued guidance, teaching, mentorship and support. I also thank Cristine Hine,
Xaioxuan Cai and Brian C Merry, for their help and support with this project. This study
was supported by grants from the US National Institute on Drug Abuse (R21-DA029914,
P50-DA09241, and K12-DA000167) and the Veterans Health Administration Mental
Illness Research, Education and Clinical Center (West Haven, CT, USA).

iii
TABLE OF CONTENTS
Abstract

i

Acknowledgements

ii

Introduction
Substance Use in Pregnancy: Scope of the Problem

1

Effects of Cocaine Use In Pregnancy

4

Risk Factors of Substance Use in Pregnancy

8

Risk Factors of Cocaine Use in Pregnancy

9

Statement of Purpose
Specific Aim 1: To identify predictors of frequency of cocaine use

13
14

in pregnancy
Specific Aim 2: To describe patterns of cocaine use in pregnancy

15

Methods
Participants

15

Procedures

16

Measures

17

Statistical Analyses

20

Statement of Responsibility

20

Participants

21

Results
TABLE 1. Characteristics for N= 50 participants

Cocaine Use in Pregnancy
Figure 1. Cocaine use Trajectory: Cocaine Use Frequency

21
22
23

by Month in Pregnancy

Correlates of Cocaine Use in Pregnancy
TABLE 2. Correlates of degree of cocaine use in pregnancy by NRB analysis

Discussion

23
24
25

Limitations

30

Clinical Implications

32

References

32

1
INTRODUCTION
According to the 2013 National Survey of Drug Use and Health (NSDUH), the use of
illicit substances in pregnancy has risen substantially over the last decade.1 This is a
critical concern, as there are more deaths, disabilities and illnesses from substance abuse
than from any other preventable health condition in the United States.2 Data from the
2002-2003 NSDUH, a nationally representative epidemiological survey, found cocaine to
be the third most commonly used illicit substance in pregnancy, following marijuana and
prescription drug abuse.3 Below we review the literature on the epidemiology and risk
factors associated with substance use during pregnancy, with particular attention to
cocaine use and subsequent complications for maternal and neonatal health.

Substance Use in Pregnancy: Scope of the Problem
About one in four pregnant women report substance use in pregnancy, with the
prevalence of tobacco and alcohol use highest at about 19% and 10% of pregnant women
respectively.3 Pregnant women who smoke cigarettes have increased risk of negative
pregnancy outcomes, including ectopic pregnancy, premature rupture of membranes,
placental abruption, placenta previa and stillbirth.4 Tobacco use also imposes risk to the
neonate, including preterm birth, low birth weight or intrauterine growth restriction, birth
defects such as cleft lip and sudden infant death syndrome (SIDS).4 Similarly, alcohol use
in pregnancy is associated with poor birth outcomes. Fetal alcohol syndrome is the
leading preventable birth defect, with impairments in physical, mental and behavioral
development.5 Moreover, fetal alcohol spectrum disorder is associated with preterm birth,
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low birth weight and failure to thrive, as well as position brain damage, vision and
hearing problems and major organ defects.6

About 5.4% of pregnant women used illicit drugs in the prior 30 days according to
NSDUH from 2012-2013, almost doubling the estimated 3% in 2002.1 The rates varied
substantially by age, with 14.6% illicit use among women aged 15 to 17, 8.6% among
women aged 18 to 25 and 3.2% among women aged 26 to 44.1 These figures are still
considered a low estimate, as perceived negative judgment, as well as legal and social
consequences, may lead women to underreport use.7

Marijuana, the most commonly used illicit drug among pregnant women, has been
associated in some studies with intrauterine growth restriction, developmental deficits in
childhood and predisposition for future addition in adolescence.8-10 Non-medical use of
prescription drugs has increased by 400% since the late 1990s, with opioid related deaths
now surpassing deaths from motor vehicle accidents and suicides in the United States.11
In parallel to this increase, non-medical prescription drugs are now second to marijuana
use in prevalence in pregnancy.1 As a consequence, the number of infants born addicted
to drugs who develop neonatal abstinence syndrome (NAS) has increased significantly.12
These infants have dysfunction in the nervous system, manifesting in tremors, irritability,
inability to self-soothe, and seizures.13 They also have respiratory problems and
gastrointestinal dysfunction, and are more likely to be lower in birth weight.14

According to the National Epidemiological Survey on Alcohol and Related Conditions
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(a nation-wide probability sample survey), the 12-month point prevalence for a cocaine
use disorder in the general population is 0.27%. 15 This estimate is about one-half that
for any use of cocaine, including crack cocaine, in the past month among individuals
age 12 or older.16 Estimates for any use of cocaine in the prior month have remained
stable (between 0.5-0.7% of the population) over the past five years.

The reported prevalence of cocaine use in pregnancy varies immensely depending on
method of assessment, gestational period of assessment and population characteristics.17
In a single hospital study (N=462) based in New Orleans, more than 3% of women had a
positive urine test for cocaine metabolites, 18 a rate similar to what was found in Florida
among urine samples collected from 715 pregnant women.19 These rates were higher than
a probability sample of pregnant women in California that collected over twenty nine
thousand urine samples from women and found a rate of 1.1% for positive cocaine tests.20
A study by Savitz et al 2002, estimated the prevalence based on self-report and urine test
to be from 2-6%, and hair assays to be around 15% in a prenatal care center in North
Carolina. This rate is similar to patients identified by cocaine-positive urine screening in
the early 1990s in Boston City Hospital (17%)6 and Pinellas County, Florida public
health clinics (15%),19,21 yet much higher than 0.3%-1% (up to 49,000) estimates based
on 2013 NSDUH self-reported data.16

Given the multiple social and environmental determinants of drug use, variability of the
prevalence over time and location is expected. Overall, most reported estimates are
reasonably close to national survey estimates of 0.3% to 1% for cocaine use in
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pregnancy, though some outliers report much higher use. Cocaine use in pregnancy can
thus affect close to 200,000 women every year, and subsequently has an impact on
maternal, neonatal and developmental outcomes as well as societal and economic
consequences.

Effects of Cocaine Use In Pregnancy
In the 1980s and early 1990s, there was much attention and concern given to cocaine use
in pregnancy. With the emergence of crack, a smoke-able, less expensive form of
cocaine, there was a change in the demographic of individuals who use cocaine from
middle-and upper class young urban professionals to men and women of lower
socioeconomic status.22 Crack use by pregnant women led to what was known as an
epidemic of “crack babies.” This resulted quickly in public outcry and the initiation of
several studies to understand the effects of cocaine in pregnancy. These early studies had
findings that more recent studies have found to be exaggerated.23-26 Nonetheless, more
controlled, longer-term studies published later have shown that effects of cocaineexposure are variable, and may be due to a combination of biological effects of cocaine
use as well as genetic and environmental factors associated with cocaine use.

Cocaine produces prolonged adrenergic stimulation by blocking the presynaptic uptake of
norepinephrine, serotonin and dopamine.27,28 While dopamine’s prolonged activity in the
limbic system and cortex lead to cocaine’s euphoric effects, the prolonged catecholamine
activity results in cardiovascular complications, such as hypertension, tachycardia, and
arrhythmias. Myocardial ischemia and infarction can occur as a result of thrombosis or
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vasospasm. In pregnancy, there is increased sensitivity to the cardiovascular effects of
cocaine29, and maternal complications can include premature labor, placental abruption,
uterine rupture, and death.30-32 A retrospective case-control study of 200 cocaine-exposed
maternal-neonatal pairs from 1991 to 2000 found that cocaine use was correlated with
premature rupture of membranes (23% vs 0% p=0.000), preterm delivery (40% vs 6%,
p=0.000) fetal demise (5% vs 0% p=0.004), preterm delivery, lower birth weights (2660
vs 3305g p=0.000), more respiratory distress (14% vs 4%, p=0.001), and longer hospital
stays (10 vs 3 days, p=0.000).33 There may also be a dose-dependent effect, such that
more cocaine exposure leads to more severe outcomes in head circumference, infant tone
and behavior.34,35 Literature reviews similarly find that numerous studies report
significant increases in these obstetric and neonatal complications in women who use
cocaine36,37 although the earlier studies showed more robust associations and may not
have accounted for the effects of poly-substance use and other confounding factors.26
Indeed, it is difficult to isolate the effect of cocaine use, given cocaine using women also
have obstetric risk from correlates of use including inadequate nutrition, higher incidence
of sexually transmitted infections and physical abuse.38 However, data from two
comprehensive, multicenter prospective investigations comparing women who used
multiple substances in pregnancy found that cocaine use was a predominant risk factor
for preterm birth, when systematically controlling for other substances and predictors of
preterm birth.39

The largest study to evaluate the impact of substance use, in particular cocaine use, in
pregnancy- the Maternal Lifestyle Study (MLS), began in the 1990s and is still ongoing
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at four research sites (University of Miami, University of Tennessee at Memphis, Wayne
State University, and Brown University). In one article published from this study, 717
cocaine-exposed infants were compared with 7448 non-cocaine exposed infants.40 Infants
that were cocaine exposed on average were 1 week younger in gestational age, 322 g less
in weight, 1.7 cm shorter and were 1.0cm smaller in head circumference than the noncocaine-exposed group. The cocaine-exposed infants also had more central nervous
system symptoms (adjusted OR 1.7; 99% CI 1.2-2.2) and infections (OR 3.1; 99% CI
1.8-5.4). Bada et al. went on to report in another study using MLS data that central
nervous system signs were highest in infants exposed to both opiates and cocaine.41

Beyond the risk to infant health from prenatal exposure to drugs, there are increased
health risks if mothers continue to use illicit substances postpartum. Children can be
exposed to cocaine passively via inhalation. Data from children less than 1 year old found
that both upper and respiratory tract infections occur more commonly in children who
have positive urine tests for cocaine and its metabolites.42 Infants and young children
with cocaine positive urine tests are also more likely to be seen in the emergency room
and general pediatrician visits than children who do not have positive urine tests for
cocaine, controlling for socio-demographic factors.42

The effects of cocaine on parenting, and early childhood through adolescent development
have been studied as well. Maternal cocaine use is associated with higher psychological
distress in mothers43 and higher rates of abuse and neglect.44,45 Cocaine using postpartum
mothers are more likely to suffer from depression, stress, paranoia, psychotic symptoms
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and anxiety.43 Richardson et al 2008 performed a longitudinal, prospective study of 295
mothers and infants, and found that women who used cocaine in pregnancy rated their
infants as more fussy or difficult and inadaptable than women who did not use. 46 When
cocaine-using mothers are evaluated during infant feeding, they are found to be less
flexible and have more conflict than mothers who are drug free.47-49 A 2012 review by
Nephew et al concluded that cocaine use can drastically affect maternal behavior, thus
leading to child neglect and disruption of mother-child bond and subsequent detrimental
effects on health and development of offspring.50 Observational studies of children and
mothers who use cocaine show that mothers with cocaine use have difficulty developing
maternal behaviors, such as recognizing infant cues and engaging with their child.49,51,52

The effects of cocaine use during pregnancy on child development are often complicated
by other exposures that occur during pregnancy. Nonetheless, Richardson et al found
that cocaine use in the second trimester was associated with significantly lower motor
development compared to no exposure or exposure during other trimesters, hypothesizing
that cocaine exposure affects development through changes in neurotransmitter
systems.46 Other studies in the past decade have found cocaine exposure to effect early
language development53,54 as well as have small, but significant effects on adolescent
development.55 The MLS study mentioned above also followed 1056 children
longitudinally to study development, and found that after controlling for confounders
(including other drug use) that internalizing, externalizing and total behavior problem
scores were higher for high prenatal cocaine exposure than for some or no use, and these
results persisted to age seven.56
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The societal and economic impact of cocaine use is significant. The cost of crime, health
related problems and reduced work productivity attributed to cocaine use are nearly $300
billion US dollars annually.23 Maternal cocaine use often results in the removal of the
infant from custody within the first 18 months of life, 57 and is the leading cause of infant
placement by state welfare agencies.58 Minnes et al found that heavier cocaine use, lack
of prenatal care, and more severe psychological symptoms all increase the likelihood of
loss of custody of the newborn.59

Risk Factors of Substance Use in Pregnancy
Numerous studies have explored risk factors for alcohol, tobacco and illicit substance use
in pregnancy. Tobacco use in pregnancy is associated with less education, lower
socioeconomic status, late or no prenatal care, public or no health insurance, being
unmarried, lack of social support, legal problems, mental illness, early age of onset of
tobacco use, and having partners who smoke.8,60-64 Alcohol use in pregnancy is linked
with having partners who have a history of substance use, unwanted pregnancy, previous
participation in alcohol or drug treatment programs, as well as late or no prenatal care.65
Additionally, women who ascribe greater social importance of alcohol in their lives are
more likely to use alcohol in pregnancy.66 In contrast to the characteristics of women who
use tobacco in pregnancy, those using alcohol have been shown to have higher income,
more education and be older in some studies, but concurrent alcohol and tobacco use in
pregnancy tends to follow tobacco use in that women are more likely to have less
education, low levels of social support and poor mental health.67 Illicit substance use in
pregnancy is associated with having comorbid mental illness,68-71 being unmarried or
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unemployed,3,72 and identifying as non-Hispanic, White.3,65 Illicit substance users in
pregnancy are also more likely to use tobacco or other substances during
pregnancy.69,73,74 Trauma and history of abuse have additionally been linked to illicit drug
use in pregnant women.75,76

Risk Factors of Cocaine Use in Pregnancy
Despite what is known of the health, social, and economic consequences of cocaine use
in pregnancy, few studies have looked specifically at predictors of cocaine use in
pregnancy.

A Toronto, Canada based case-control study of over 1600 women from 1985 to 1990
found that women who had been exposed to cocaine during pregnancy were younger,
more likely to be single (60% single women using cocaine vs 38% and 14% in two
control groups, p<0.001) and have a higher incidence of elective abortion. A high
percentage of women who use cocaine endorsed cannabinoid use (46%) and alcohol and
cigarette consumption was also higher in the cocaine group. Additionally, both women
who use cocaine and the male partners of these cocaine-using women had a significantly
lower socioeconomic status (p<0.001) than control women or their partners.

Bendersky et al found similar results regarding poly-substance use and environmental
risk factors for cocaine use in pregnancy.70 Their study of cocaine positive pregnant
women in two inner cities (Trenton, NJ and Philadelphia, PA) found that cocaine-positive
women were more likely to smoke cigarettes, have less stable living situations, live in
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environments where substance use was high, have less social support, rely on public
assistance and report family history of alcoholism or drug abuse. In contrast to the results
from the Toronto study, Bendersky et al found that individuals who use cocaine tended to
be older in age.70 Older age as a predictor of cocaine use was also found in later studies,
such as Shieh et al. They conducted a cross-sectional study comparing pregnant
cocaine/heroin using women with marijuana using women at a prenatal clinic in
northeast, United States and found that pregnant heroin or cocaine using women tend to
be older (about 6 years older), have experienced more pregnancies, have more severe
drug use scores, and have initiated care later than marijuana users.77

Kissin et al expanded on these environmental risk factors, especially the nature of social
support.78 They conducted a descriptive study of characteristics of 240 pregnant opioid
and/or cocaine dependent women in Baltimore, MD 1994 and 1995, admitted to
treatment. They found that women initiated use ranging from 12 to 38 years old, and over
half of women reported drug use was initiated by a friend (53%) followed by a family
member (27%) and/or sexual partner (24%). With regards to social support, almost half
of women reported having no close friends and 28% reported spending the majority of
their free time alone. Cocaine and/or opioid using women who ended up losing custody
of their children were more likely to be homeless, have less education, more medical and
employment problems, more previous drug treatment episodes and more recent cocaine
use.78
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Beyond the environmental and demographic risk factors associated with cocaine use in
pregnancy, few studies have reported on health and psychological risk factors. Strickland
et al 1993 reported on a small study of 21 postpartum urban African-American women,
10 of whom had infants who tested positive for cocaine at parturition. Through clinical
interviews, they found that a cocaine positive mothers scored significantly higher on
depression (F=4.44, p<0.05) and sociopathy (F=13.48, p,0.002) than cocaine-negative
mothers.79 A study of 143 postpartum women in a Midwest hospital found that poor,
primarily African American urban women who used cocaine in pregnancy were more
likely to report increased psychological distress than non-cocaine using women of similar
racial and socioeconomic status.43

One case-control study of over 200 pregnant women in Detroit, MI recruited from 19931994 similarly found that cocaine using pregnant women had higher depression scores
(OR: 1.09, p<0.05).80 In addition to depression, they found other significant predictors in
their regression model, which are in agreement with those of Bendersky et al 1996 and
Kissin et al 2006. Cocaine using women who used drugs in pregnancy were more likely
to have been introduced to substance use by a male partner (OR: 5.37, p<0.05), have a
family history of drug or alcohol problems (OR: 3.16, p<0.05), endorse less social
support (OR: 2.16, p<0.05), have less-stable living situations (OR: 1.25, p<0.05), and
have current partners who were substance users (OR: 1.43, p<0.05), compared to women
who did not use cocaine in pregnancy.80 In addition, they found that poly-substance use
was common to all illicit drug users, but in particular those using cocaine. In fact, heavy
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cigarette use (at least half-pack per day use) was the single strongest predictor of cocaine
and other substance use in pregnancy (OR: 10.8, p<0.05).80

As the aforementioned studies all utilized self-report as their primary screening tool, a
case-control study published by Savitz and colleagues in 2002 utilized urine assays,
postpartum hair assays and self-report to identify cocaine-using women and indicators of
cocaine exposure in pregnancy. Through these additional screening methods, they were
able to build a large study of over 2600 women in prenatal care in North Carolina, and
found strong demographic predictors of exposure. They found a markedly higher
prevalence of cocaine use among younger, black, less educated, poorer women. Race,
education and income were associated with adjusted risk ratios for cocaine exposure as
high as 3 to 6, such that black women with low education and socioeconomic status had a
prevalence of 52% exposure using hair assays.

Mitsuhiro and colleagues in São Paulo, Brazil, similarly utilized hair analysis to identify
cocaine and marijuana using women in a population of 1000 teenagers in the third
trimester of pregnancy. They found that those testing positive for cocaine were mostly
from low-income, inner city areas, unmarried, and unemployed and less educated.81

In summary, few studies have specifically looked at determinants of cocaine use in
pregnancy, but those studies from the 1990s to 2010s that have reported on various
demographic, social and psychological risk factors have been surprisingly consistent,
despite differences in time, location and population. Most agree that family history of
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substance abuse, less stable environments, drug use by partners and family, less social
support, poly-substance use and depression are associated with positive cocaine use in
pregnancy. Identifying these factors is important, as surveillance of illicit drug use is
difficult.82 Urine toxicology screening is expensive, only sensitive to specific time
frames, and tends to be racially motivated.83 Use of hair for assessment is limited by
differences in hair texture and color affecting results.82 Self-report surveys remain the
most prevalent choice for surveillance of drug use,2,82 thus targeting screening and
improving screening using known risk factors may aid in identifying women who are
likely to underreport use.84 Though identification of women and improved interventions,
we can begin to reduce cocaine related complications of pregnancy for mothers, children
and society.

STATEMENT OF PURPOSE
Despite what is known about the potentially harmful effects of drugs during pregnancy,
the prevalence of substance use in pregnancy, including alcohol and tobacco, is still
greater than 25%. 3 The use of illicit substances in pregnancy, in particular, has risen over
the last decade, reaching upwards of 5.4% as of 2013.1 This figure is still considered a
low estimate, given that maternal drug use is frequently underreported.7

Understanding factors that differentiate women who achieve abstinence from those who
continue to use drugs in pregnancy is of great importance to improving screening and
targeting interventions to ultimately impact maternal and fetal health outcomes. Multiple
studies have described correlates of smoking 61-64,85, alcohol 65-67,86 and general illicit or
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poly-substance abuse in pregnancy. 72,73,78,87,88 Few studies exist to specifically look for
predictors of cocaine use in pregnancy. 22,38,80 Cocaine use in pregnancy, though less
prevalent than smoking or alcohol use 1, is associated with poor birth outcomes, including
preterm birth, intrauterine growth restriction and low birth weight as well as increased
complications during pregnancy, such as placental abruption, and maternal migraines and
seizures. 7 To our knowledge, no studies yet exist to identify factors that may predict
level or severity of cocaine use in pregnancy. This information could further guide health
providers in focusing limited resources and screening toward those women who are at
risk for more severe cocaine use in pregnancy, thereby reaching those at greatest
likelihood for detrimental health outcomes. This study will seek to identify factors that
predict frequency of cocaine use in pregnancy and discuss implications for health
communication and screening.

Specific Aim 1: To identify predictors of frequency of cocaine use in pregnancy
Hypothesis #1: Several factors will be associated with heavier cocaine use in pregnancy
(1) Severity of cocaine use at baseline (prior to pregnancy) will significantly impact
cocaine use in pregnancy, with mild cocaine use at baseline predicting greater
abstinence from cocaine use in pregnancy and more moderate to severe use at
baseline predicting heavier cocaine use in pregnancy.
(2) Age at first onset of cocaine use will significantly impact cocaine use in
pregnancy, with earlier age of onset predicting heavier cocaine use in pregnancy.
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(3) The presence of a comorbid mental illness, such as major depressive disorder,
dysthymia, mania, hypomania, generalized anxiety disorder, or PTSD will predict
heavier cocaine use in pregnancy.
(4) Concurrent use of alcohol, marijuana or other drugs during pregnancy will predict
heavier cocaine use in pregnancy.
(5) Trauma will be predictive of cocaine use in pregnancy, with a history of greater
traumatic life events predicting heavier cocaine use in pregnancy.
(6) Lack of social support from spouses, parents, siblings, relatives, friends and social
structures will predict heavier cocaine use in pregnancy.

Specific Aim 2: To describe patterns of cocaine use in pregnancy
Hypothesis #2: Cocaine use will decrease from the
first to third trimesters of pregnancy, with the majority of women achieving abstinence by
the 9th month of pregnancy.

METHODS
Participants
Participants included 50 postpartum women with a history of cocaine abuse or
dependence who were enrolled in a randomized control trial to determine the efficacy of
progesterone in decreasing postpartum cocaine use. Participants were recruited from
obstetric practices and substance abuse treatment centers in the greater New Haven,
Connecticut area as well as by referral from Yale New Haven Hospital, St. Raphael’s’
Hospital of New Haven, and other study participants. Women were eligible if they were
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aged 18 and older, spoke English, were less than 3 weeks postpartum at time of intake,
and met DSM IV criteria for abuse or dependence of cocaine in the six-months prior to
conception or during pregnancy. Women who abused other illicit substances or alcohol
were eligible as long as cocaine was their primary drug of abuse. If women were also
opiate dependent, they must have been undergoing treatment with methadone or
buprenorphine. Because women were enrolled in a trial in which they would be receiving
progesterone or placebo, women were excluded if they had a history of a major medical
illness that would be a contraindication to treatment with progesterone, such as clinically
significant liver disease suspected or known malignancy, thrombophlebitis, or history of
clot or embolus. Data collection began in 2010 and concluded in 2013. Approval for the
trial was obtained from the Human Investigation Committee at Yale University School of
Medicine and from affiliated hospitals, and all participants provided verbal and written
consent.

Procedures
Women in this study participated in a randomized control trial examining the use of
progesterone to reduce postpartum cocaine use. For treatment and procedure details, see
Yonkers, et. al 2014.89 All participants completed a computerized intake assessment, in
which they retrospectively reported cocaine and other drug use during pregnancy, and
answered questions on psychiatric and social history. In addition to the computer
assessment, participants met with a researcher who performed the MINI international
diagnostic interview 90. The responses from this initial intake visit, which occurred on
average within the first week postpartum, were used in this study to analyze correlates of
cocaine use in pregnancy.
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Measures
Dependent Variable
The aim of this study was to identify correlates of cocaine use in pregnancy. To elicit
cocaine use during pregnancy, participants were asked to retrospectively, self-report on
cocaine use and frequency during each month of pregnancy. For example, participants
were asked, “Did you use cocaine in the first month of pregnancy?” If participants
responded yes, they were asked, “During the first month of pregnancy, how often did you
use?” Responses were obtained on the following scale: 0=No Use, 1=less than once a
month, 2=about once a month, 3=2-3 times a month, 4=1-3 times a week, 5=4-6 times a
week, 6=once daily, 7=twice daily, 8=three or more times daily. The dependent variable
was operationalized as the reported frequency of cocaine use for each month of
pregnancy.
Independent Variables
The independent variables of interest included: severity of cocaine use at baseline, age at
first onset of cocaine use, comorbid mental illness, poly-substance use, lifetime trauma
history, and social support.
(1) Severity of cocaine use at baseline was determined by the amount of cocaine use in
the 6 months prior to pregnancy. Women were asked, “How often did you use cocaine or
crack, on average, during the six months before you became pregnant?” Use amounts
were recorded on a scale of frequency of use, with 0= less than once a month, 1=about
once a month, 2=2-3 times a month, 3=1-2 times a week, 4=4-6 times a week, 5=once
daily, 6=twice daily and 7=three or more times daily. Results were then grouped into
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three categories. “Mild use” was operationalized as cocaine use less than once per week
(0-2 on the scale), “moderate use” as cocaine use less than daily (3-4 on the scale), and
“Severe use” as cocaine use daily or more (5-7 on the scale).

(2) Age at first onset of cocaine use was determined by asking women “How old were
you when you first used cocaine or crack?” The number in years from 1-50 was recorded.

(3) Comorbid mental illness was defined as meeting MINI international diagnostic
interview criteria for major depressive disorder, dysthymia, mania, hypomania,
generalized anxiety disorder, or PTSD. 90

(4) Poly-substance use was defined as positive report of alcohol, marijuana or other drug
use during pregnancy. Women were asked, “During the first month of this pregnancy,
did you have a drink of wine, beer or liquor? We understand-you might not have even
known that you were pregnant yet. Please answer as accurately as possible.”

(5) Lifetime trauma history was determined by self-report of number of traumatic life
events, including sexual, physical and emotional trauma. Women were asked 13
questions relating to traumatic experiences, such as “Have you ever experienced rape,
that is, someone had sexual intercourse with you when you did not want to by threatening
you or using some degree of force? Have you ever been sexually molested, that is,
someone touched you in a way that made you feel uncomfortable? Have you ever
experienced serious physical attack or assault? Have you ever been threatened with a
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weapon, held captive, or kidnapped?” A final “trauma score” was coded as the total
number of positive responses to this series of 13 questions.

(6) Social support was determined using questions from a modification of the Kendler
Social Support Inventory, which has been shown to significantly predict depression in
pregnant women 91. 24 items assessed personal relationships with spouse, mother, father,
siblings, other relatives and friends. For each relationship domain, participants were
asked about frequency of contact and emotional quality of interactions. For example,
participants were asked, “How frequently do you and your mother see each other,
talk/text on the phone, or communicate by letter or computer (email or social network)?”
and responses ranged from 0-5 for frequency of support. Emotional quality of support
questions included, “How much does she listen to you if you need to talk about your
worries or problems?” “How much does she understand the way you feel and think about
things?” and “How much does she go out of her way to help you if you really need it?”
Responses ranged from 1-5 for emotional support questions. Finally, 3 items assessed
frequency of contact with church groups, clubs/organizations and confidants. A total
“social support score” was coded as the composite score of the 27 items in the
assessment.

Confounding Variables
Variables that were considered possible confounders, and, therefore, held constant
throughout the analysis included age of participant, race of participant, marital status of
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participant, employment status of participant and the involvement of the Department of
Children and Families within the home.

Statistical Analyses
All statistical analyses were conducted in SAS version 9.3. Multiple models were tried to
determine the model that would best fit the varied response types within this complex
assessment. Ultimately, the GLMM Negative Binomial Regression model was selected,
as it best accounted for correlation within subjects and the high zero-inflated distribution
of response variables and is most appropriate for retrospective data. Analyses were
conducted using backward selection methods. First, independent variables of interest
were tested individually for their potential to be included in the model. Variables that did
not significantly affect the frequency of cocaine use in pregnancy or were not clinically
relevant were excluded, and a multivariate model was fit with the remaining variables.
Different variance-covariance matrix and link function were compared before the model
was finalized.

Statement of Responsibility
This researcher, Regina Melendez, was responsible for performing participant
recruitment and screening as well as conducting weekly assessments, including intake,
treatment and follow-up assessments, with participants from June-August 2012, along
with Cristine Hine, LCSW. This researcher operationalized the variables of interest for
the study. Xiaoxuan Cai, research assistant at Yale School of Public Health, performed
the statistical analysis. Regina Melendez, Xiaoxuan Cai, Kimberly Yonkers, MD and
Brian Merry, MPH interpreted the results.
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RESULTS
Participants
Table 1 presents an overview of the social, demographic and health characteristics of the
50 participants. Overall, participants were approximately 31 years of age at intake
TABLE 1. Characteristics for N= 50 participants
Characteristic
Age at Intake
Education (in years)
Age at onset of cocaine use
Social support score
Trauma score

Mean (SD)
31.5 (5.5)
12.4 (2.2)
19.9 (5.3)
58.9 (23.6)
4.1 (2.4)
N (%)

Race; Ethnicity
White; Non-Hispanic
Black; Non-Hispanic
White; Hispanic
Black; Hispanic
Marital Status
Married
Separated/ divorced
Dating, living together
Dating, not living together
Single
Comorbid Mental Illness
Major Depressive Disorder
Anxiety
PTSD
Mania or Hypomania
Dysthymia
Severity of cocaine use at baseline
Mild use (< 1/week)
Moderate use (>1/week, <1/day)
Severe use (>1/day)
Poly-substance use during pregnancy
Alcohol
Marijuana
Other drugs
DCF involvement in household*
Employed within the last 6 months
*DCF = Department of Children and Families

28 (56%)
14 (28%)
3 (6%)
4 (8%)
2 (4%)
8 (16%)
9 (18%)
7 (14%)
24 (48%)
13 (26%)
14 (28%)
13 (36%)
12 (24%)
24 (48%)
11 (22%)
17 (34%)
22 (44%)
28 (56%)
21 (42%)
14 (28%)
20 (40%)
10 (21%)
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(M=31.5, SD=5.5) and had an average of high school level education (M=12.4 years,
SD=2.2). About half of participants identified as Caucasian (56%), with the remaining
identifying as Black, non-Hispanic (14%) and Hispanic (14%). More than half of women
reported using alcohol or illicit substances during pregnancy, with 56% percent reporting
alcohol use, 42% marijuana use, 28% other drug use. The mean age of onset of cocaine
use was about 20 years old (M=19.9, SD=5.3). The mean social support score was 58.9
(SD 23.6) with responses ranging from 11 to 119. The mean trauma score was 4.1
(SD=2.4) with a responses ranging from 0 to 9.

Cocaine Use in Pregnancy
Figure 1 depicts the cocaine use trajectory of participants from the first to ninth month of
pregnancy. Cocaine use overall trended downward as pregnancies progressed. Indeed,
negative binomial regression analysis of time in months yielded a coefficient of -0.27
(SD=0.03, p=<0.0001). In other words, every month increase in time was associated
with a 0.27 decrease in level of cocaine. Level of frequency/degree of cocaine use was
coded on nine different levels, the lowest representing no use and the highest representing
three or more times daily usage. By the ninth month of pregnancy 40 women (80% of
participants) had achieved abstinence as defined by no cocaine use in the past month.
Beyond demonstrating the overall downward trajectory of cocaine use in pregnancy,
Figure 1 shows that multiple participants who reported abstinence at earlier months in
pregnancy relapsed in later months. Therefore, while overall use decreased, fluctuations
month to month were common for multiple participants.
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Figure 1. Cocaine use Trajectory: Cocaine Use Frequency by Month in Pregnancy
Level of
Frequency of
Cocaine Use
0= No use
1= Less than
once a month
2= about once
a month
3=2-3 times a
month
4=1-3 times a
week
5=4-6 times a
week
6= once daily
7= twice daily
8= three or
more times
daily
Time (Months)

Correlates of Cocaine Use in Pregnancy
Table 2 presents the results of the negative binomial regression analysis examining the
relationship between independent parameters and cocaine use in pregnancy. The
strongest correlate of cocaine use in pregnancy was baseline cocaine use six months prior
to pregnancy. Severe baseline cocaine (daily or greater cocaine use) compared to mild or
less than weekly baseline cocaine use was associated with a 2.88 increase in the degree of
cocaine use in pregnancy (SD=0.57, p <0.0001). Similarly, moderate baseline cocaine
use (weekly or greater cocaine use prior to pregnancy) was associated with a 2.58
increase in degree of cocaine use (SD= 0.57, p<0.0001). Marijuana use was the third
strongest correlate of degree of cocaine use in pregnancy, with positive marijuana use in
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pregnancy being associated with a 1.24 increase in frequency of cocaine use compared to
women who did not use marijuana (SD=0.24, p<0.0001).

Age at onset of cocaine use and social support were both statistically significant, but
more weakly associated with higher degrees of cocaine use in pregnancy. For each year
increase in age of cocaine use onset, there was a 0.13 increase in cocaine use in
pregnancy (SD=0.04, p=0.0017). Therefore, older ages of onset of cocaine were
associated with mildly higher degrees of cocaine usage. For each point increase in social
support score, there was a 0.016 increase in cocaine use frequency (SD=0.008,
p=0.0413). Therefore, for higher reported social support levels, there was a mildly higher
degree of cocaine usage. Comorbid mental illness, alcohol or other drug use during
pregnancy and lifetime trauma score were not statistically significant and were excluded
from the model.

TABLE 2. Correlates of degree of cocaine use in pregnancy by NRB analysis
Standard
Parameter
Coeff.
Error
p Value
Time
-0.265
0.032
<0.0001
Moderate Baseline
Cocaine Use
Severe Baseline
Cocaine Use
Age at Onset of
Cocaine Use
Marijuana Use in
Pregnancy
Social Support Score

95% CI
-0.331 - -0.200

2.583

0.567

<0.0001

1.443-3.723

2.880

0.563

<0.0001

1.749-4.012

0.128

0.039

0.0017

0.051-0.206

1.235

0.237

<0.0001

0.759-1.711

0.016

0.008

0.0413

0.001-0.032

NBR= negative binomial regression, Coeff. = Negative binomial coefficient
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DISCUSSION
According to the National Survey on Drug Use and Health (NSDUH), about 11% of
women between the ages of 15 and 44 are currently using illicit drugs, including
cocaine.1 Many of these individuals include women who are considering becoming
pregnant, are pregnant or may already be parenting children. Indeed, according to some
reports, 5% of pregnant women admit to illicit substance use to care-providers, and this
is likely an underestimate of substance use in pregnancy.3 Given what is known about
the harmful effects of illicit drugs on the health outcomes of both the mother and
newborn, this trend is very concerning. Cocaine use in pregnancy is particularly
deleterious, as it holds known risk for significant obstetric complications and increased
neonatal morbidity33 and has been associated with child abuse and neglect44, separation
of the child from the parent’s home59,92,93 and delays in development from infancy
through adolescence.46,53-55,94
Previous work has shown that women with a history of cocaine abuse or dependence can
drastically decrease their use during pregnancy. In one study of cocaine use in
pregnancy, researchers found women spent 14% of days using cocaine at the beginning
of pregnancy, which decreased to 2% by 9 months of pregnancy.89 Our study revealed a
similar trend, with 80% of women achieving abstinence from cocaine by the 9th month of
pregnancy. The affect of time in pregnancy on cocaine use is consistent with studies of
other substance use, such as alcohol and tobacco use in pregnancy.3 This finding may be
the result of many influences. First, differences between use in the first and second
trimesters may represent self-discontinuation of use upon the learning of the pregnancy.
Moreover, this finding may reflect knowledge of the negative effects of substance use in
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pregnancy, and subsequent motivation to preserve the health of the newborn. Also,
cultural and social influences may be at play, as women who are more progressed in
pregnancy may feel pressured by negative perceptions of others. Finally, hormonal
changes in pregnancy may account for this finding. Progesterone production increases
during pregnancy from 40 mgs/24 hours in the luteal phase to 250 mgs/24 hours in late
pregnancy. Women also experience massive changes in levels of estrogen, as
production of β-estradiol increases from less than 1 mg/24 hours pre-pregnancy to 1520 mgs/24 hours in late pregnancy. Data from a multitude of preclinical studies suggest
that these hormones and their active metabolites affect a wide range of central nervous
system functions, and may be implicated in cocaine addiction.89 In addition to the
downward trend of cocaine use over pregnancy, this study demonstrates that women’s
use can fluctuate month to month, suggesting that factors other than time in pregnancy
play a role in a woman’s decision to use cocaine in pregnancy.
Several factors associated with frequency of cocaine use in pregnancy emerged from this
study. The most strongly correlated factor with increased cocaine use in pregnancy was
severity of use in the 6 months prior to pregnancy. Some researchers contend that
frequency of use is a less robust measure of severity, as it does not take into account the
impact of drug use on the individual’s global functioning and interpersonal
relationships.77 In our study, this was of less concern, as women were not simply cocaine
positive or exposed in their lifetime, but rather were only eligible if they met DSM-IV
criteria for abuse or dependence on the MINI International Interview, which incorporates
drug-related medical, family, employment, legal and financial problems as part of the
assessment.90 Frequency of use, therefore, served as a proxy for comparing severity
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amongst this subset of cocaine using women. In this study, there was good heterogeneity
between different levels of use, as 11 women (22%) reported mild use (<1/week), 17
women (34%) reported moderate use (>1/week, <1/day) and 22 women (44%) reported
severe use (>1/day). The levels of baseline use described as moderate and severe were
both strongly associated with significantly higher frequencies of cocaine use in
pregnancy. This finding suggests that those women who have more frequent use have
more severe addiction, and therefore would have greater difficulty achieving abstinence
in pregnancy.

Poly-substance use with marijuana was another correlate of heavier cocaine use in
pregnancy. This is consistent with the literature, which shows that poly-substance use is
associated with more severe addiction; and in particular, cocaine use in pregnancy is
strongly correlated with poly-substance use.70,80 Additionally, previous reports that have
found that marijuana use in adolescence, often considered “gateway” drug use, predicts
other illicit drug use in adulthood.24 One Toronto based study of over 1600 women found
that of individuals who use cocaine, cannabinoids were used by as high as 46%.22 Patton
et. al found that those who used marijuana were nearly five times more likely to use
cocaine.24 This finding suggests that women who chose to use, or have access to one
illicit drug, are more likely to repeat risky behavior and use other illicit substances.
Individuals who use cocaine, in particular, tend to be poly-substance users, 80 and
marijuana is the most used illicit substance in pregnant and non-pregnant adults.1 Other
studies have shown that women who use cocaine in pregnancy tend to have greater
alcohol use,70 and though alcohol use at any time in pregnancy was prevalent in this study
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(56%), it was not a significant correlate of frequency of cocaine use. The conclusion that
marijuana use is associated with more frequent cocaine use in pregnancy has important
clinical implications, as women may be more likely to report marijuana use than cocaine
use, for less fear of legal repercussions and more societal acceptance of marijuana use.
Thus screening with self-report may focus on marijuana behaviors to begin to identify
women at high risk for cocaine use in pregnancy. Indeed, the Substance Use Risk Profile
Pregnancy Scale uses marijuana as a screening tool to identify women at risk of alcohol
and drug use in pregnancy, with 100% sensitivity and 64% specificity in low-risk
populations.95
Later age at onset of first cocaine use was weakly correlated with heavier cocaine use in
pregnancy. This finding did not support our hypothesis that earlier age of first cocaine
use would be associated with more severe use in pregnancy. Multiple studies have
shown that earlier age of onset of substance use, particularly alcohol and tobacco, predict
substance abuse later in life.24 With regards to substance use in pregnancy, one nationally
representative study found that initiation of smoking at greater than 15 years of age was
associated with increased likelihood of abstinence during pregnancy, concluding that the
earlier a woman initiates smoking, the more likely it is that she will smoke during
pregnancy.60 It is possible that onset of cocaine use differs from than that of tobacco and
alcohol, and therefore results of impact of age of onset may not be generalizable to
individuals who use cocaine. Indeed, most studies report that individuals who endorse
cocaine use tend to be older than other drug users77,78 In a 2013 national survey, median
onset of cocaine use was 20.4, compared to 17.8 years for tobacco users and 18 years for
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marijuana. Our participants had an average age of onset of cocaine use of 19.9 years
(SD= 5.3), reflective of the national average.
Greater social support was associated with mildly heavier cocaine use, which was
unexpected, as our hypothesis was that less social support would predict greater cocaine
use. Previous studies have found that cocaine using pregnant women tend to have less
social support.78,80 This study’s opposing finding may be due to the nature of the measure
we used for social support. The Kendler Social Support Inventory has been used to
predict depression in pregnant women, and responses are recorded on scales of frequency
of contact with partners, family and friends as well as women’s perceived emotional
quality of these contacts. 91 It is possible that women who are having more severe cocaine
use in pregnancy are reporting greater frequency of contact with family as a result of the
consequences of drug-related behaviors, such as financial instability. In other words,
support may be higher as a response to heavy-substance using women’s greater needs in
pregnancy. Whether the interactions are positive or negative cannot be established based
on frequency of contact and therefore future studies may consider placing greater weight
on the emotional quality of social support when attempting to measure this factor in
substance abusing women.
The theory that social support in this population may be a negative factor is supported by
results from a case-control study of 200 pregnant women in Detroit, MI, which found that
both introduction to alcohol or drugs by a male partner and substance use by family
members had a greater effect than other psychosocial risk factors in predicting cocaine
use in pregnancy.80 In their study, more than one-third of drug users reported that a male
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partner had supplied drugs to them as some point. Another study of 240 cocaine and/or
opioid dependent women in Baltimore, MD found that similarly over half of women
reported that drug use was initiated by a friend (53%), family member (27%) and/or
sexual partner (24%).78 Although women in their study reported close relationships
among family, almost half reported having no close friends and 28% reported spending
the majority of their free time alone.78 These results taken together suggest that there may
be a contextual negative influence of social support in cocaine abusing pregnant women.
This knowledge provides a novel implication for screening, as women may be more
likely to disclose information on drug use of male partners or other family than self-use.
The lack of significance of comorbid mental illness on frequency of cocaine use was
unexpected. Multiple studies have shown that mental health issues co-occur with
substance use 71 and may be linked to continued use in pregnancy or relapse to use
postpartum.61,68,79,96 Our failure to find an impact of mental health may be due to limited
power, though there was fair representation of women meeting MINI criteria for major
depressive disorder (26%), Anxiety (28%), PTSD (36%), Mania (24%) and Dysthymia
(48%). In addition, trauma history was not a significant factor for increased cocaine use
in pregnancy for our participants, though mean trauma score was 4.1 (SD=2.4) out of 13
possible points, and some women reported as high as 9 positive responses to trauma
events. Again, while previous studies have linked trauma history or abuse with substance
use75,76, this study may not have had sufficient power to find this association.
Limitations
There are several limitations of this study. First, as mentioned above, this study had a
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small sample size (N=50), which may have led to factors whose correlation was
underestimated or deemed insignificant. Pregnant, substance-using women may delay or
avoid prenatal care; cocaine-using women may be particularly less likely to endorse use
or interact with healthcare for risk of legal and social consequences.3,7 It is difficult
therefore, to find sizable studies with this population, and more nationally representative
studies on factors influencing the decision to use substances, particularly cocaine, are
needed.3 Second, this study used data from women who had voluntarily enrolled in a
treatment program for cocaine use postpartum, and most were recruited for the study in
pregnancy. Therefore these women had demonstrated motivation in pregnancy or
postpartum to abstain from cocaine use, so these results may not capture risk factors for
cocaine using pregnant women who lack motivation for abstinence and may potentially
be the most severe users. Of note, however, 44% of women in this study did report daily
cocaine use in the 6 months prior to pregnancy, and at the first month of pregnancy the
average reported use of cocaine was weekly use. Third, recruitment was restricted to the
New Haven area of Connecticut, so the conclusions we draw here may not be
generalizable to all areas of the United States. Studies show that there can be great
variability in patterns of use in different regions of countries.37 Lastly, the self-reported
use in our study has potential for recall bias, as women were asked to recount cocaine use
frequency over multiple months, after having completed their pregnancy. Moreover,
urine toxicology screening could not corroborate cocaine use retrospectively. While this
is a limitation, it is important to consider that recall as a modality for assessing use in this
population may be a strength as well, as women have less incentive to misreport past use
for fear of the repercussions of reporting, or fear of negative outcomes of pregnancy.
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Clinical Implications
Current screening and identification of substance using women who are pregnant is
very poor.97 This study identified several factors that can be used by clinicians as
correlates of heavier cocaine use in pregnancy, and subsequently serve as a guide for
improving screening and directing resources for education of pregnant, cocaine using
women. Most screening by providers is done by self-report.80 Based on this study’s
findings, evaluation of a patient’s history for baseline cocaine use, concurrent marijuana
use, age at onset of cocaine use, and social support can aid in detection of more frequent
cocaine use during pregnancy. In particular, positive self-report of greater than weekly
cocaine use prior to pregnancy or marijuana use during pregnancy should provide the
strongest impetus for further attention. More studies are needed to further understand
how social support is assessed for cocaine using pregnant women, as drug involved
families or male partners may impede a woman’s ability to abstain from cocaine use in
pregnancy and may skew our understanding of social support strength for these women.
In addition to implications for screening, understanding risk factors for drug use in
pregnancy can help in designing more effective prevention as well as treatment
strategies. To that end, this study adds to our understanding of risk factors for cocaine
use in pregnancy, and larger, more nationally representative studies are needed in the
future to further this understanding.
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